erlotinib hydrochloride has been researched along with gant 61 in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (gant 61) | Trials (gant 61) | Recent Studies (post-2010) (gant 61) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 160 | 0 | 150 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | gant 61 (IC50) |
|---|---|---|---|
| Zinc finger protein GLI1 | Mus musculus (house mouse) | 5 | |
| Zinc finger protein GLI2 | Mus musculus (house mouse) | 5 | |
| Sonic hedgehog protein | Mus musculus (house mouse) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheraghzadeh, Z; Ghanbari, A; Hosseini, E; Mahmoudi, R; Zibara, K | 1 |
1 other study(ies) available for erlotinib hydrochloride and gant 61
| Article | Year |
|---|---|
GLI inhibitors overcome Erlotinib resistance in human pancreatic cancer cells by modulating E-cadherin.
Topics: Apoptosis; Cadherins; Cell Proliferation; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Erlotinib Hydrochloride; Gene Expression Regulation, Neoplastic; Humans; Pancreatic Neoplasms; Pyridines; Pyrimidines; Signal Transduction; Tumor Cells, Cultured; Zinc Finger Protein GLI1 | 2019 |